Audentes Therapeutics (NASDAQ:BOLD) Stock Price Up 5.5% on Earnings Beat
Audentes Therapeutics Inc (NASDAQ:BOLD) rose 5.5% during mid-day trading on Friday following a stronger than expected earnings report. The stock traded as high as $30.00 and last traded at $28.57, approximately 614,594 shares traded hands during mid-day trading. An increase of 25% from the average daily volume of 490,504 shares. The stock had previously closed at $27.08.
The biotechnology company reported ($1.00) EPS for the quarter, beating analysts’ consensus estimates of ($1.07) by $0.07. During the same quarter in the prior year, the company posted ($0.97) earnings per share.
BOLD has been the subject of a number of analyst reports. ValuEngine downgraded shares of Audentes Therapeutics from a “buy” rating to a “hold” rating in a research report on Friday. Robert W. Baird initiated ...